Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000160

CEO & President sold 1,565 shares at $457.00 ($715,205)

  • CEO & President acquired 1,565 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kewalramani Reshma · CEO & President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-24 Exercise or conversion : show line 1 in the form 10b5-1 +1,565 $187.53 $293,484 122,939 D
2024-05-24 Sale : show line 2 in the form 10b5-1 −1,565 $457.00 $715,205 121,374 D
Open-market sales · 1,565 sh · avg $457.00 · $715,205

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-05-24 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −1,565 $187.53 2029-02-05 1,565 0 D
Loading xslF345X05/wk-form4_1717013304.xml…